ArticleImmunotherapy2025

Disparities in utilization of novel cancer therapies in advanced stage III and IV melanoma and variance in outcomes.

Mohammad S Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.